| 0.6 |
1.7 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.1 |
0.7 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.2 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 |
0.3 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.1 |
0.2 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
0.6 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.7 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 |
0.2 |
GO:1904588 |
cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 |
0.9 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 |
0.2 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.0 |
0.4 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.0 |
0.1 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.0 |
0.1 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.0 |
0.1 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.0 |
0.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.1 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.0 |
0.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.1 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.0 |
0.1 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.0 |
0.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.0 |
GO:0071676 |
negative regulation of mononuclear cell migration(GO:0071676) allantois development(GO:1905069) |
| 0.0 |
0.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
